Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    February 2024
  1. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
    The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
    J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
    PubMed     Abstract available


  2. OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al
    Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by collagenofibrotic glomerulopathy. A nephrology picture.
    J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875.
    PubMed    


    January 2024
  3. TRIMARCHI H, Fervenza FC, Coppo R
    Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
    J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833.
    PubMed     Abstract available


  4. HE WJ, Wang J, Liu N, Li GY, et al
    The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839.
    PubMed     Abstract available


    December 2023
  5. SCHENA FP, Cox SN
    Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861.
    PubMed    


  6. BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al
    A membranous nephropathy in a 5 year-old boy: and if that's not all? A nephrology quiz.
    J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821.
    PubMed    


    November 2023
  7. ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al
    Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
    J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803.
    PubMed     Abstract available


  8. BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al
    SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.
    J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777.
    PubMed     Abstract available


  9. RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al
    General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.
    J Nephrol. 2023;36:2269-2280.
    PubMed     Abstract available


  10. GOTO K, Imaizumi T, Hamada R, Ishikura K, et al
    Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    J Nephrol. 2023;36:2257-2267.
    PubMed     Abstract available


  11. XIONG L, Liu L, Tao Y, Guo H, et al
    Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
    J Nephrol. 2023;36:2213-2222.
    PubMed     Abstract available


  12. RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al
    Hydroxychloroquine in nephrology: current status and future directions.
    J Nephrol. 2023;36:2191-2208.
    PubMed     Abstract available


  13. SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al
    Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    J Nephrol. 2023;36:2281-2293.
    PubMed     Abstract available


  14. WANG F, Jin Y, Zhou F, Luo L, et al
    Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    J Nephrol. 2023;36:2295-2304.
    PubMed     Abstract available


  15. ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al
    The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy.
    J Nephrol. 2023;36:2223-2231.
    PubMed     Abstract available


  16. ALVAREZ L, Kambham N, Su R
    Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    J Nephrol. 2023;36:2365-2370.
    PubMed     Abstract available


    October 2023
  17. LIU Z, Wan C, Cao Y, Liu S, et al
    Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
    J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779.
    PubMed     Abstract available


  18. PALA C, Parenti E, Vizzini G, Gianfreda D, et al
    Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789.
    PubMed     Abstract available


  19. MONGERA N, Passler W, Sethi S, Kozakowski N, et al
    A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation.
    J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786.
    PubMed    


    September 2023
  20. PAOLO SF, Natasha CS
    Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745.
    PubMed    


  21. AI S, Yan X, Zhao X, Ye W, et al
    Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
    J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751.
    PubMed     Abstract available


  22. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
    Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
    J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
    PubMed     Abstract available


  23. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
    Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
    PubMed    


    August 2023
  24. TERINTE-BALCAN G, Stancu S, Zugravu A, Capusa C, et al
    Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    J Nephrol. 2023 Aug 26. doi: 10.1007/s40620-023-01744.
    PubMed     Abstract available


  25. CEOL M, Gianesello L, Trimarchi H, Migliorini A, et al
    Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin?
    J Nephrol. 2023 Aug 18. doi: 10.1007/s40620-023-01725.
    PubMed     Abstract available


    July 2023
  26. LU H, Li Y, Lai M, Guan T, et al
    Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study.
    J Nephrol. 2023 Jul 31. doi: 10.1007/s40620-023-01685.
    PubMed     Abstract available


  27. VASURI F, Lisi AP, Ciavarella C, Degiovanni A, et al
    Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathy.
    J Nephrol. 2023 Jul 22. doi: 10.1007/s40620-023-01645.
    PubMed     Abstract available


  28. KOBAYASHI H, Satake E, Murata Y, Otsuka H, et al
    Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
    J Nephrol. 2023 Jul 12. doi: 10.1007/s40620-023-01704.
    PubMed     Abstract available


    June 2023
  29. WATANABE H, Yamana H, Okada A, Matsui H, et al
    Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
    J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695.
    PubMed     Abstract available


  30. JANKOWSKI E, Schlosser M, Wiech T, Wolf G, et al
    SARS-CoV-2 infection: a possible trigger for the recurrence of IgA nephropathy after kidney transplantation?
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01684.
    PubMed     Abstract available


  31. FAN Y, Kang D, Chen Z, Lu Y, et al
    Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies.
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01622.
    PubMed     Abstract available


  32. ZAPPI S, Bernasconi L, Fischer I, Hoxha E, et al
    Lesson for the clinical nephrologist: thrombospondin type-1 domain-containing protein 7A-associated membranous nephropathy and Fanconi syndrome in a patient with a squamous cell lung cancer.
    J Nephrol. 2023 Jun 9. doi: 10.1007/s40620-023-01630.
    PubMed    


  33. ZHANG L, Du M, Tu Y, Liang D, et al
    Clinicopathological features and long-term prognosis of glomerular diseases associated with mercury-containing cosmetics.
    J Nephrol. 2023;36:1401-1407.
    PubMed     Abstract available


    May 2023
  34. WEHRMANN F, von Bergwelt-Baildon A, Schonermarck U
    Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle.
    J Nephrol. 2023 May 31. doi: 10.1007/s40620-023-01659.
    PubMed    


  35. AGRAWAL A, Chong GY, Fidler ME, Cramer Ii CH, et al
    Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression.
    J Nephrol. 2023;36:1169-1174.
    PubMed     Abstract available


    April 2023
  36. SOMA Y, Kato M, Shimura G, Kamio M, et al
    Renal biopsy diagnosis of IgG4-related kidney disease with minor hematuria and mild renal dysfunction: lessons for the clinical nephrologist.
    J Nephrol. 2023;36:639-642.
    PubMed    


  37. ZHU M, Wang J, Le W, Xu F, et al
    Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease.
    J Nephrol. 2023;36:789-797.
    PubMed     Abstract available


    March 2023
  38. LACETERA R, Calatroni M, Roggero L, Radice A, et al
    Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review.
    J Nephrol. 2023 Mar 20. doi: 10.1007/s40620-023-01574.
    PubMed     Abstract available


  39. LI JP, Du YT, Guo C, Rao XR, et al
    IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAkappa deposits: a pattern switch.
    J Nephrol. 2023 Mar 13. doi: 10.1007/s40620-023-01583.
    PubMed     Abstract available


  40. HE G, Tao L, Li C, Zhong X, et al
    The spectrum and changes of biopsy-proven kidney diseases in Chinese children.
    J Nephrol. 2023;36:417-427.
    PubMed     Abstract available


    February 2023
  41. RONSIN C, Jacquemont L, Testa A, Renaudin K, et al
    ANCA-negative pauci-immune crescentic glomerulonephritis associated with Fabry disease: lesson for the clinical nephrologist.
    J Nephrol. 2023 Feb 16. doi: 10.1007/s40620-022-01533.
    PubMed    


  42. FONTANA F, Delsante M, Vicari M, Pala C, et al
    Mycophenolate mofetil plus steroids compared to steroids alone in IgA nephropathy: a retrospective study.
    J Nephrol. 2023 Feb 15. doi: 10.1007/s40620-023-01578.
    PubMed    


  43. SU X, Song R, Li S, Guo W, et al
    Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
    J Nephrol. 2023 Feb 14. doi: 10.1007/s40620-022-01550.
    PubMed     Abstract available


    January 2023
  44. VILLEGAS-GAMAS JM, Marquez-Macedo SE, Jimenez-Franco B, Fonseca-Correa JI, et al
    Proliferative glomerulonephritis with monoclonal IgG deposits triggered by Filgrastim in a patient with multiple myeloma.
    J Nephrol. 2023 Jan 18. doi: 10.1007/s40620-022-01555.
    PubMed    


  45. LIE DNW, Chan KW, Tang AHN, Chan ATP, et al
    Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study.
    J Nephrol. 2023 Jan 11. doi: 10.1007/s40620-022-01530.
    PubMed     Abstract available


  46. TANAKA M, Moniwa N, Nogi C, Kano T, et al
    Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy.
    J Nephrol. 2023 Jan 9. doi: 10.1007/s40620-022-01551.
    PubMed     Abstract available


    December 2022
  47. HE L, Wang H, He P, Jiang Y, et al
    Serum Long Noncoding RNA H19 and CKD Progression in IgA Nephropathy.
    J Nephrol. 2022 Dec 27. doi: 10.1007/s40620-022-01536.
    PubMed     Abstract available


  48. BAIER E, Kluge IA, Hakroush S, Tampe D, et al
    Leukocyturia and hematuria enable non-invasive differentiation of Bowman's capsule rupture severity in PR3-ANCA glomerulonephritis.
    J Nephrol. 2022 Dec 21. doi: 10.1007/s40620-022-01486.
    PubMed     Abstract available


  49. HUANG Z, Hu Y, Chen B, Liang Y, et al
    Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
    J Nephrol. 2022 Dec 20. doi: 10.1007/s40620-022-01511.
    PubMed     Abstract available


  50. KADEMANI SP, Nelaturi P, Sathyasagar K, Ravikumar S, et al
    Noncoding RNAs associated with IgA nephropathy.
    J Nephrol. 2022 Dec 10. doi: 10.1007/s40620-022-01498.
    PubMed     Abstract available


  51. ALLINOVI M, Lugli G, Rossi F, Palterer B, et al
    Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature.
    J Nephrol. 2022 Dec 3. doi: 10.1007/s40620-022-01528.
    PubMed    


  52. POPA O, Capusa C, Stefan G, Mandache E, et al
    How useful is kidney biopsy for the management of glomerulopathies in the elderly?
    J Nephrol. 2022;35:2301-2312.
    PubMed     Abstract available


  53. MOGUEL GONZALEZ B, Garcia Nava M, Orozco Guillen OA, Soto Abraham V, et al
    Kidney biopsy during pregnancy: a difficult decision. A case series reporting on 20 patients from Mexico.
    J Nephrol. 2022;35:2293-2300.
    PubMed     Abstract available


    November 2022
  54. STAI S, Lioulios G, Christodoulou M, Papagianni A, et al
    From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
    J Nephrol. 2022 Nov 30. doi: 10.1007/s40620-022-01493.
    PubMed     Abstract available


  55. GREVE AS, Prakash S, Krag S, Randers E, et al
    Focal segmental glomerulosclerosis in a patient with multiple sclerosis treated with Teriflunomide and Ocrelizumab.
    J Nephrol. 2022 Nov 21. doi: 10.1007/s40620-022-01504.
    PubMed     Abstract available


    October 2022
  56. SCHENA FP, Anelli VW, Di Noia T, Tripepi G, et al
    Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy.
    J Nephrol. 2022 Oct 21. pii: 10.1007/s40620-022-01463.
    PubMed     Abstract available


  57. CLAUDIO P
    Primary membranous nephropathy: an endless story.
    J Nephrol. 2022 Oct 17. pii: 10.1007/s40620-022-01461.
    PubMed     Abstract available


  58. DE SOUZA L, Ismail I, Baade R, Mantha M, et al
    Lessons for the clinical nephrologist: dialysis decisions in early pregnancy for acute kidney injury due to post-infectious glomerulonephritis (PIGN).
    J Nephrol. 2022 Oct 14. pii: 10.1007/s40620-022-01464.
    PubMed    


  59. CHBIHI M, Eveillard LA, Riller Q, Brousse R, et al
    Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
    J Nephrol. 2022 Oct 8. pii: 10.1007/s40620-022-01438.
    PubMed     Abstract available


    September 2022
  60. SEIKRIT C, Schimpf JI, Wied S, Stamellou E, et al
    Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study.
    J Nephrol. 2022 Sep 15. pii: 10.1007/s40620-022-01454.
    PubMed     Abstract available


  61. XU L, Kant S, Aqeel F, Antiochos B, et al
    Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    J Nephrol. 2022 Sep 9. pii: 10.1007/s40620-022-01460.
    PubMed    


    August 2022
  62. TAMPE D, Baier E, Hakroush S, Tampe B, et al
    Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    J Nephrol. 2022 Aug 13. pii: 10.1007/s40620-022-01414.
    PubMed     Abstract available


  63. STEFAN G, Zugravu A, Stancu S
    Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.
    J Nephrol. 2022 Aug 12. pii: 10.1007/s40620-022-01426.
    PubMed    


    July 2022
  64. WU Q, Liang D, Song T, Ni X, et al
    Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    J Nephrol. 2022 Jul 22. pii: 10.1007/s40620-022-01385.
    PubMed     Abstract available


  65. XIE M, Zhu Y, Wang X, Ren J, et al
    Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.
    J Nephrol. 2022 Jul 4. pii: 10.1007/s40620-022-01363.
    PubMed     Abstract available


    May 2022
  66. PICCOLI GB
    The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis?
    J Nephrol. 2022 May 11. pii: 10.1007/s40620-022-01343.
    PubMed    


  67. OKI R, Unagami K, Taneda S, Takagi T, et al
    Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    J Nephrol. 2022 May 6. pii: 10.1007/s40620-022-01332.
    PubMed     Abstract available


  68. TAMPE D, Hakroush S, Biggemann L, Winkler MS, et al
    Kinetics of human leukocyte antigen receptor HLA-DR(+) monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis.
    J Nephrol. 2022;35:1283-1287.
    PubMed     Abstract available


  69. TESAR V, Hruskova Z
    Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients.
    J Nephrol. 2022;35:1065-1068.
    PubMed    


  70. MAKATI D, Akers J, Aljuhani M, Pellegrino B, et al
    Prevalence of ANCA-associated vasculitis amid natural gas drilling sites in West Virginia.
    J Nephrol. 2022;35:1185-1192.
    PubMed     Abstract available


    April 2022
  71. LIU M, Yu X, Wang S, Qin A, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
    PubMed     Abstract available


  72. DUAN T, Zhu X, Zhao Q, Xiao L, et al
    Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.
    J Nephrol. 2022 Apr 18. pii: 10.1007/s40620-022-01316.
    PubMed     Abstract available


  73. HAKROUSH S, Kluge IA, Baier E, Korsten P, et al
    pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis.
    J Nephrol. 2022 Apr 5. pii: 10.1007/s40620-022-01320.
    PubMed    


    March 2022
  74. RUAN Y, Hong F, Wu J, Lin M, et al
    Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    J Nephrol. 2022 Mar 15. pii: 10.1007/s40620-022-01273.
    PubMed     Abstract available


  75. DEL VECCHIO L, Locatelli F, Ponticelli C
    The treatment of membranous nephropathy: a journey in the search for evidence.
    J Nephrol. 2022 Mar 1. pii: 10.1007/s40620-022-01291.
    PubMed    


  76. REZAC J, Honsova E, Masek M, Rysava R, et al
    Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma.
    J Nephrol. 2022;35:675-678.
    PubMed    


    February 2022
  77. FAUCON AL, Cereja S, Mussini C, Goujon JM, et al
    Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.
    J Nephrol. 2022 Feb 24. pii: 10.1007/s40620-022-01278.
    PubMed    


  78. BOSE B, Chung EYM, Hong R, Strippoli GFM, et al
    Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    J Nephrol. 2022 Feb 23. pii: 10.1007/s40620-022-01268.
    PubMed     Abstract available


    December 2021
  79. HAKROUSH S, Tampe B
    Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    J Nephrol. 2021 Dec 1. pii: 10.1007/s40620-021-01208.
    PubMed     Abstract available


  80. WANG K, Yu Z, Huang Y, Yang K, et al
    Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.
    J Nephrol. 2021;34:1887-1896.
    PubMed     Abstract available


    November 2021
  81. CHENG YJ, Cheng XY, Zhang YM, Wang F, et al
    Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
    J Nephrol. 2021 Nov 30. pii: 10.1007/s40620-021-01182.
    PubMed     Abstract available


  82. CALISKAN Y, Demir E, Karatay E, Ozluk Y, et al
    Oxidative stress and macrophage infiltration in IgA nephropathy.
    J Nephrol. 2021 Nov 16. pii: 10.1007/s40620-021-01196.
    PubMed     Abstract available


  83. MANENTI L, Rossi GM, Pisani I, Gentile M, et al
    IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.
    J Nephrol. 2021 Nov 10. pii: 10.1007/s40620-021-01189.
    PubMed     Abstract available


  84. HAKROUSH S, Gersmann AK, Tampe B
    Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis.
    J Nephrol. 2021 Nov 6. pii: 10.1007/s40620-021-01169.
    PubMed    


    October 2021
  85. GUO Y, Shi S, Zhou X, Liu L, et al
    The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.
    J Nephrol. 2021 Oct 21. pii: 10.1007/s40620-021-01176.
    PubMed     Abstract available


  86. VAJGEL G, Correia MRB, Costa CLC, Sette LH, et al
    Nephrology pictures: pemphigus vulgaris and membranous nephropathy.
    J Nephrol. 2021 Oct 15. pii: 10.1007/s40620-021-01151.
    PubMed    


  87. GUO W, Tan PH, Baikunje S
    Membranous nephropathy in a patient with COVID-19 infection.
    J Nephrol. 2021 Oct 7. pii: 10.1007/s40620-021-01165.
    PubMed    


  88. JARRICK S, Lundberg S, Stephansson O, Symreng A, et al
    Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.
    J Nephrol. 2021;34:1591-1598.
    PubMed     Abstract available


    September 2021
  89. MASSET C, Renaudin K, Kervella D, Chapelet A, et al
    Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.
    J Nephrol. 2021 Sep 24. pii: 10.1007/s40620-021-01144.
    PubMed    


    July 2021
  90. LUAN R, Tian G, Zhang H, Shi X, et al
    Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
    J Nephrol. 2021 Jul 22. pii: 10.1007/s40620-021-01118.
    PubMed     Abstract available


  91. KANT S, Arend LJ, Gapud E, Seo P, et al
    Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis.
    J Nephrol. 2021 Jul 20. pii: 10.1007/s40620-021-01126.
    PubMed     Abstract available


    June 2021
  92. GEETHA D, Attarwala N, Zhang C, Kant S, et al
    Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    J Nephrol. 2021 Jun 28. pii: 10.1007/s40620-021-01095.
    PubMed     Abstract available


  93. BINET Q, Aydin S, Lengele JP, Cambier JF, et al
    Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.
    J Nephrol. 2021;34:935-938.
    PubMed     Abstract available


    May 2021
  94. NAGAI M, Kobayashi N, Izumi N, Ohbayashi T, et al
    Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
    J Nephrol. 2021 May 20. pii: 10.1007/s40620-021-01064.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.